Price
$16.02
Increased by +4.43%
Dollar volume (20D)
16.38 M
ADR%
5.26
Shares float
63.26 M
Shares short
21.40 M [33.83%]
Shares outstanding
170.92 M
Market cap
2.64 B
Beta
0.61
Price/earnings
N/A
20D range
13.36 16.16
50D range
12.72 18.96
200D range
12.72 34.47

Immunovant, Inc., a clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases.

It develops IMVT-1402 for graves' disease, rheumatoid arthritis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, cutaneous lupus erythematosus disease, and sjögren's disease; and batoclimab for graves' disease and thyroid eye disease.

The company has a license agreement with HanAll Biopharma Co., Ltd. for the rights of intellectual property relating to IMVT-1402 and batoclimab.

Immunovant, Inc. was founded in 2018 and is based in New York, New York.

Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Mar 31, 25 -0.64
Decreased by -23.08%
-0.72
Increased by +10.73%
Feb 10, 25 -0.76
Decreased by -111.11%
-0.75
Decreased by -1.02%
Nov 7, 24 -0.74
Decreased by -64.44%
-0.60
Decreased by -23.33%
Aug 6, 24 -0.60
Decreased by -5.26%
-0.53
Decreased by -13.21%
May 29, 24 -0.52
Decreased by -13.04%
-0.43
Decreased by -20.93%
Feb 12, 24 -0.36
Increased by +26.53%
-0.43
Increased by +16.28%
Nov 9, 23 -0.45
Decreased by -9.76%
-0.47
Increased by +4.26%
Aug 10, 23 -0.57
Decreased by -62.86%
-0.45
Decreased by -26.67%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Mar 31, 25 160.00 K
Decreased by -89.33%
-106.45 M
Decreased by -41.33%
Decreased by -66.53 K%
Decreased by -1.22 K%
Dec 31, 24 0.00
Decreased by N/A%
-111.12 M
Decreased by -116.11%
Decreased by N/A%
Decreased by N/A%
Sep 30, 24 0.00
Decreased by N/A%
-109.12 M
Decreased by -86.01%
Decreased by N/A%
Decreased by N/A%
Jun 30, 24 0.00
Decreased by N/A%
-87.15 M
Decreased by -17.87%
Decreased by N/A%
Decreased by N/A%
Mar 31, 24 1.50 M
Increased by +N/A%
-75.32 M
Decreased by -26.73%
Decreased by -5.02 K%
Decreased by N/A%
Dec 31, 23 0.00
Decreased by N/A%
-51.42 M
Increased by +18.68%
Decreased by N/A%
Decreased by N/A%
Sep 30, 23 0.00
Decreased by N/A%
-58.66 M
Decreased by -22.40%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by N/A%
-73.94 M
Decreased by -83.13%
Decreased by N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY